famotidine has been researched along with Prostatic Hyperplasia in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gould, AL | 1 |
1 other study available for famotidine and Prostatic Hyperplasia
| Article | Year |
|---|---|
Bayesian analysis of multicentre trial outcomes.
Topics: Antacids; Bayes Theorem; Double-Blind Method; Drugs, Investigational; Famotidine; Finasteride; Heart | 2005 |